Should you buy VFY.AX stock?
Last updated:
Based on market data through , StockInvest.us rates Vitrafy Life Sciences Ltd. (VFY.AX) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. This is a downgrade from Strong Buy in the previous daily evaluation.
- Hold signal since
- Price since signal Up 22.00%
- 3-month trend forecast Up 28.62%
- Easy Tracking In The Watchlist
On Tuesday, Vitrafy Life Sciences Ltd. stock price gained an impressive 6.22%
(Market data through Aug 11, 2026)
The Vitrafy Life Sciences Ltd. stock price gained 6.22% on the last trading day (Tuesday, 11th Aug 2026), rising from A$4.02 to A$4.27. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 6.70% from a day low at A$4.03 to a day high of A$4.30. The price has risen in 6 of the last 10 days and is up by 38.19% over the past 2 weeks. Volume fell on the last day by -6 thousand shares and in total, 80 thousand shares were bought and sold for approximately A$343.51 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at A$4.47 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 28.62% during the next 3 months and, with a 90% probability hold a price between A$3.96 and A$5.75 at the end of this 3-month period.
VFY.AX Signals & Forecast
The Vitrafy Life Sciences Ltd. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at A$3.90 and A$3.22. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, July 13, 2026, and so far it has risen 55.27%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Support, Risk & Stop-loss for Vitrafy Life Sciences Ltd. stock
On the downside, the stock finds support just below today's level from accumulated volume at A$3.99 and A$3.85. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Vitrafy Life Sciences Ltd. finds support just below today's level at A$3.99. If this is broken, then the next support from accumulated volume will be at A$3.85 and A$3.50.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved A$0.270 between high and low, or 6.70%. For the last week the stock has had daily average volatility of 7.55%.
The Vitrafy Life Sciences Ltd. stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.
Our recommended stop-loss: A$4.12 (-3.57%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 91 and this increases the risk substantially. There is a buy signal from a pivot bottom found 21 days ago.)
Trading Expectations (VFY.AX) For The Upcoming Trading Day Of Wednesday 12th
For the upcoming trading day on Wednesday, 12th we expect Vitrafy Life Sciences Ltd. to open at A$4.20, and during the day (based on 14 day Average True Range), to move between A$4.15 and A$4.39, which gives a possible trading interval of +/-A$0.239 (+/-5.76%) up or down from last closing price. If Vitrafy Life Sciences Ltd. takes out the full calculated possible swing range there will be an estimated 5.76% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ A$3.99, some A$0.280 (6.56%) from the current price of A$4.27, our system finds the risk reward attractive.
Is Vitrafy Life Sciences Ltd. stock A Buy?
Vitrafy Life Sciences Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold candidate.
Current score:
0.000
Hold/Accumulate
Downgraded
Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.
Predicted Fair Opening Price
Predicted fair opening price on August 12, 2026 - A$4.20 ( 1.64%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
VFY.AX Performance
Trading levels for VFY.AX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 4.47 | 4.68% |
| R2 | 4.37 | 2.27% |
| R1 | 4.30 | 0.776% |
| Price | 4.27 | |
| S1 | 4.10 | -4.05% |
| S2 | 4.03 | -5.55% |
| S3 | 3.93 | -7.96% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 4.27 | |
| S1 | 3.99 | -6.56% |
| S2 | 3.85 | -9.84% |
| S3 | 3.50 | -18.03% |
FAQ
Click here for our free guide on how to buy Vitrafy Life Sciences Ltd. Stock.
Buy VFY